Linking the p53 tumour suppressor pathway to somatic cell reprogramming

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673 · see citing works

Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors

Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221 · see citing works

Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · see citing works

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · see citing works

Generation of germline-competent induced pluripotent stem cells

Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,438 · see citing works

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063 · see citing works

Reprogramming of human somatic cells to pluripotency with defined factors

Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H.-G., Ince, T., Lerou, P., Lensch, M., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 3,028 · see citing works

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2007) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,781 · see citing works

Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins

Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K. Y., Lanza, R., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.05.005 · Cited by 1,814 · see citing works

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626 · see citing works

A novel form of Epstein-Barr virus latency in normal B cells in vivo

Miyashita, E. M., Yang, B., Lam, K. M. C., Crawford, D., & Thorley‐Lawson, D. A. (1995) · Cell · doi:10.1016/0092-8674(95)90513-8 · Cited by 1,591 · see citing works

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53

Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521 · see citing works

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes

Aasen, T., Raya, A., Barrero, M. J., Garreta, E., Consiglio, A., Gonzalez, F., Vassena, R., Bilić, J., Pekarik, V., Tiscornia, G., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt.1503 · Cited by 1,423 · see citing works

Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2

Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., Muhlestein, W. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt.1502 · Cited by 1,342 · see citing works

A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy

Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270 · see citing works

Development of a self-inactivating lentivirus vector

Miyoshi, H., Blömer, U., Takahashi, M., Gage, F. H., & Verma, I. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8150-8157.1998 · Cited by 1,196 · see citing works

Induction of pluripotent stem cells from fibroblast cultures

Takahashi, K., Okita, K., Nakagawa, M., & Yamanaka, S. (2007) · Nature Protocols · doi:10.1038/nprot.2007.418 · Cited by 1,080 · see citing works

Generation of human induced pluripotent stem cells from dermal fibroblasts

Lowry, W. E., Richter, L., Yachechko, R., Pyle, A. D., Tchieu, J., Sridharan, R., Clark, A. T., & Plath, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711983105 · Cited by 1,041 · see citing works

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2

Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., & Sherr, C. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8292 · Cited by 899 · see citing works

Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Oct4 and Klf4 with Small-Molecule Compounds

Shi, Y., Desponts, C., Tae, J., Hahm, H. S., Schöler, H. R., & Ding, S. (2008) · Cell stem cell · doi:10.1016/j.stem.2008.10.004 · Cited by 898 · see citing works

p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression

Lin, T., Chao, C., Saito, S., Mazur, S. J., Murphy, M. E., Appella, E., & Xu, Y. (2004) · Nature Cell Biology · doi:10.1038/ncb1211 · Cited by 859 · see citing works

Generation of Pluripotent Stem Cells from Neonatal Mouse Testis

Kanatsu-Shinohara, M., Inoue, K., Lee, J., Yoshimoto, M., Ogonuki, N., Miki, H., Baba, S., Kato, T., Kazuki, Y., Toyokuni, S., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.011 · Cited by 814 · see citing works

A core Klf circuitry regulates self-renewal of embryonic stem cells

Jiang, J., Chan, Y.-S., Loh, Y., Cai, J., Tong, G., Lim, C.-A., Robson, P., Zhong, S., & Ng, H. (2008) · Nature Cell Biology · doi:10.1038/ncb1698 · Cited by 746 · see citing works

Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics

Kitamura, T., Koshino, Y., Shibata, F., Oki, T., Nakajima, H., Nosaka, T., & Kumagai, H. (2003) · Experimental Hematology · doi:10.1016/j.exphem.2003.07.005 · Cited by 738 · see citing works

Conditional Suppression of Cellular Genes: Lentivirus Vector-Mediated Drug-Inducible RNA Interference

Wiznerowicz, M., & Trono, D. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8957-8951.2003 · Cited by 703 · see citing works

Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics

Kitamura, T., KOSHINO, Y., Shibata, F., et al. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00260-1 · Cited by 642 · see citing works

c-Myc Is Dispensable for Direct Reprogramming of Mouse Fibroblasts

Wernig, M., Meissner, A., Cassady, J. P., & Jaenisch, R. (2008) · Cell stem cell · doi:10.1016/j.stem.2007.12.001 · Cited by 627 · see citing works

The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene

Rowland, B. D., Bernards, R., & Peeper, D. S. (2005) · Nature Cell Biology · doi:10.1038/ncb1314 · Cited by 583 · see citing works

Two Supporting Factors Greatly Improve the Efficiency of Human iPSC Generation

Zhao, Y., Yin, X., Qin, H., Zhu, F., Liu, H., Yang, W., Zhang, Q., Xiang, C., Hou, P., Song, Z., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.10.002 · Cited by 468 · see citing works

Tailoring to RB: tumour suppressor status and therapeutic response

Knudsen, E. S., & Knudsen, K. E. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2401 · Cited by 345 · see citing works

Identification of a Minimal Transforming Domain of p53: Negative Dominance through Abrogation of Sequence-Specific DNA Binding

Shaulian, E., Zauberman, A., Ginsberg, D., & Oren, M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5581 · Cited by 341 · see citing works

Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector

Gonzãlez, F., Monasterio, M. B., Tiscornia, G., Pulido, N. M., Vassena, R., Batlle-Morera, L., Rodriguez-Piza, I., & Belmonte, J. C. (2009) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0901471106 · Cited by 324 · see citing works

Generation of Induced Pluripotent Stem Cells in the Absence of Drug Selection

Blelloch, R. H., Venere, M., Yen, J. S., & Ramalho‐Santos, M. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.08.008 · Cited by 278 · see citing works

Reprogramming Efficiency Following Somatic Cell Nuclear Transfer Is Influenced by the Differentiation and Methylation State of the Donor Nucleus

Blelloch, R. H., Wang, Z., Meissner, A., Pollard, S. M., Smith, A. G., & Jaenisch, R. (2006) · Stem Cells · doi:10.1634/stemcells.2006-0050 · Cited by 277 · see citing works

From Bench to Bedside A Novel Technique of Acquiring OCT Images

Prati, F., Cera, M., Ramazzotti, V., Imola, F., Giudice, R., Giudice, M., Propris, S. D., & Albertucci, M. (2008) · Circulation Journal · doi:10.1253/circj.72.839 · Cited by 253 · see citing works

MDMX: from bench to bedside

Marine, J.-C. W., Dyer, M. A., & Jochemsen, A. G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03362 · Cited by 228 · see citing works

Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF.

Foster, K. W., Ren, S., Louro, I. D., Lobo-Ruppert, S. M., McKie-Bell, P., Grizzle, W. E., Hayes, M., Broker, T. R., Chow, L. T., & Ruppert, J. M. (1999) · PubMed · Cited by 187 · see citing works

Guanine nucleotide biosynthesis is regulated by the cellular p53 concentration.

Sherley, J. L. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54302-7 · Cited by 95 · see citing works

Increased Radioresistance and Accelerated B Cell Lymphomas in Mice with Mdmx Mutations that Prevent Modifications by DNA-Damage-Activated Kinases

Wang, Y. V., Leblanc, M., Wade, M., Jochemsen, A. G., & Wahl, G. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.008 · Cited by 79 · see citing works

Molecular cloning, sequencing, chromosomal localization and expression of mouse p21 (Waf1).

Huppi, K. E., Siwarski, D. F., Dosik, J. K., Michieli, P., Chedid, M., Reed, S. I., Mock, B. A., Givol, D., & Mushinski, J. F. (1994) · PubMed · Cited by 78 · see citing works

Antagonism of Myc functions by Arf

Cleveland, J. L., & Sherr, C. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.020 · Cited by 40 · see citing works

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA

Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662 · see citing works

The essence of senescence: Figure 1.

Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038 · see citing works

Mutant p53 in Cancer: New Functions and Therapeutic Opportunities

Muller, P. A. J., & Vousden, K. H. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.021 · Cited by 1,545 · see citing works

Unravelling mechanisms of p53-mediated tumour suppression

Bieging-Rolett, K. T., Mello, S. S., & Attardi, L. D. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3711 · Cited by 1,389 · see citing works

Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury

Yang, L., Besschetnova, T. Y., Brooks, C. R., Shah, J. V., & Bonventre, J. V. (2010) · Nature Medicine · doi:10.1038/nm.2144 · Cited by 1,333 · see citing works

Cellular Senescence: Aging, Cancer, and Injury

Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270 · see citing works

Somatic coding mutations in human induced pluripotent stem cells

Gore, A., Li, Z., Fung, H.-L., Young, J. E., Agarwal, S., Antosiewicz-Bourget, J., Canto, I., Giorgetti, A., Israel, M. A., Kiskinis, E., et al. (2011) · Nature · doi:10.1038/nature09805 · Cited by 1,273 · see citing works

Oncogenic roles of EMT-inducing transcription factors

Puisieux, A., Brabletz, T., & Caramel, J. (2014) · Nature Cell Biology · doi:10.1038/ncb2976 · Cited by 1,032 · see citing works

Direct cell reprogramming is a stochastic process amenable to acceleration

Hanna, J. H., Saha, K., Pando, B., van Zon, J. S., Lengner, C. J., Creyghton, M. P., van Oudenaarden, A., & Jaenisch, R. (2009) · Nature · doi:10.1038/nature08592 · Cited by 1,006 · see citing works

Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells

Loewer, S., Cabili, M. N., Guttman, M., Loh, Y., Thomas, K., Park, I. H., Garber, M. G., Curran, M. S., Önder, T. T., Agarwal, S., et al. (2010) · Nature Genetics · doi:10.1038/ng.710 · Cited by 971 · see citing works

Vitamin C enhances the generation of mouse and human induced pluripotent stem cells.

Esteban, M., Wang, T., Qin, B.-M., Yang, J.-Y., Qin, D.-J., Cai, J.-L., Li, W., Weng, Z., Chen, J.-K., Ni, S., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2009.12.001 · Cited by 989 · see citing works

Copy number variation and selection during reprogramming to pluripotency

Hussein, S. M. I., Batada, N., Vuoristo, S., Ching, R., Autio, R., Närvä, E., Ng, S., Sourour, M., Hämäläinen, R., Olsson, C., et al. (2011) · Nature · doi:10.1038/nature09871 · Cited by 992 · see citing works

Facilitators and Impediments of the Pluripotency Reprogramming Factors’ Initial Engagement with the Genome

Soufi, A., Donahue, G., & Zaret, K. (2012) · Cell · doi:10.1016/j.cell.2012.09.045 · Cited by 888 · see citing works

Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis

Rivlin, N., Brosh, R., Oren, M., & Rotter, V. (2011) · Genes & Cancer · doi:10.1177/1947601911408889 · Cited by 1,033 · see citing works

The tumorigenicity of human embryonic and induced pluripotent stem cells

Ben-David, U., & Benvenisty, N. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3034 · Cited by 889 · see citing works

A decade of transcription factor-mediated reprogramming to pluripotency

Takahashi, K., & Yamanaka, S. (2016) · Nature reviews. Molecular cell biology · doi:10.1038/nrm.2016.8 · Cited by 815 · see citing works

Cellular senescence and its effector programs

Salama, R., Sadaie, M., Hoare, M., & Narita, M. (2014) · Genes & Development · doi:10.1101/gad.235184.113 · Cited by 855 · see citing works

Induced pluripotency: history, mechanisms, and applicationsPreprint

Stadtfeld, M., & Hochedlinger, K. (2010) · Genes & Development · doi:10.1101/gad.1963910 · Cited by 827 · see citing works

Nuclear reprogramming to a pluripotent state by three approaches

Yamanaka, S., & Blau, H. (2010) · Nature · doi:10.1038/nature09229 · Cited by 799 · see citing works

The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiationPreprint

Lian, I., Kim, J., Okazawa, H., Zhao, J. J., Zhao, B., Yu, J., Chinnaiyan, A. M., Israel, M. A., Goldstein, L. S. B., Abujarour, R., et al. (2010) · Genes & Development · doi:10.1101/gad.1903310 · Cited by 738 · see citing works

The dynamic nature of senescence in cancer

Lee, S., & Schmitt, C. A. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0249-2 · Cited by 588 · see citing works

Tissue damage and senescence provide critical signals for cellular reprogramming in vivo

Mosteiro, L., Pantoja, C., Alcazar, N., Marión, R. M., Chondronasiou, D., Rovira, M., Fernandez-Marcos, P. J., Muñoz-Martin, M., Blanco-Aparicio, C., Pastor, J., et al. (2016) · Science · doi:10.1126/science.aaf4445 · Cited by 589 · see citing works

Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells

Subramanyam, D., Lamouille, S., Judson, R. L., Liu, J. Y., Bucay, N., Derynck, R., & Blelloch, R. H. (2011) · Nature Biotechnology · doi:10.1038/nbt.1862 · Cited by 594 · see citing works

Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state

Lapasset, L., Milhavet, O., Prieur, A., Besnard, E., Babled, A., Aït-Hamou, N., Leschik, J., Pellestor, F., Ramirez, J.-M., De Vos, J., et al. (2011) · Genes & Development · doi:10.1101/gad.173922.111 · Cited by 570 · see citing works

Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome

Liu, G.-H., Barkho, B. Z., Ruiz, S., Diep, D., Qu, J., Yang, S.-L., Panopoulos, A. D., Suzuki, K., Kurian, L., Walsh, C., et al. (2011) · Nature · doi:10.1038/nature09879 · Cited by 575 · see citing works

Sox2 expression in breast tumours and activation in breast cancer stem cells

Leis, O., Eguiara, A., López‐Arribillaga, E., Alberdi, M. J., Hernández-García, S., Elorriaga, K., Pandiella, A., Rezola, R., & Martín, Á. G. (2011) · Oncogene · doi:10.1038/onc.2011.338 · Cited by 518 · see citing works

Methionine Metabolism Regulates Maintenance and Differentiation of Human Pluripotent Stem Cells

Shiraki, N., Shiraki, Y., Tsuyama, T., Obata, F., Miura, M., Nagae, G., Aburatani, H., Kume, K., Endo, F., & Kume, S. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.017 · Cited by 514 · see citing works

Oncogenes and Tumor Suppressor GenesPreprint

Lee, E. Y., & Muller, W. J. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003236 · Cited by 515 · see citing works

Methods for making induced pluripotent stem cells: reprogramming à la carte

Gonzãlez, F., Boué, S., & Belmonte, J. C. I. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2937 · Cited by 504 · see citing works

LincRNA-p21 Activates p21 In cis to Promote Polycomb Target Gene Expression and to Enforce the G1/S Checkpoint

Dimitrova, N., Zamudio, J. R., Jong, R. M., Soukup, D., Resnick, R., Sarma, K., Ward, A. J., Raj, A., Lee, J. T., Sharp, P. A., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.025 · Cited by 445 · see citing works

Cellular plasticity and the neuroendocrine phenotype in prostate cancer

Davies, A. H., Beltran, H., & Zoubeidi, A. (2018) · Nature Reviews Urology · doi:10.1038/nrurol.2018.22 · Cited by 431 · see citing works

The p53 orchestra: Mdm2 and Mdmx set the tone

Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450 · see citing works

Examination of the expanding pathways for the regulation of p21 expression and activity

Jung, Y.-S., Qian, Y., & Chen, X. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.01.013 · Cited by 418 · see citing works

Primordial Germ Cells in MicePreprint

Saitou, M., & Yamaji, M. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008375 · Cited by 418 · see citing works

The cell cycle in stem cell proliferation, pluripotency and differentiation

Liu, L., Michowski, W., Kołodziejczyk, A., & Siciński, P. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0384-4 · Cited by 404 · see citing works

Promotion of direct reprogramming by transformation-deficient Myc

Nakagawa, M., Takizawa, N., Narita, M., Ichisaka, T., & Yamanaka, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009374107 · Cited by 403 · see citing works

Systemic Elevation of PTEN Induces a Tumor-Suppressive Metabolic State

Garcı́a-Cao, I., Song, M. S., Hobbs, R. M., Laurent, G., Giorgi, C., de Boer, V. C. J., Anastasiou, D., Ito, K., Sasaki, A. T., Rameh, L. E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.030 · Cited by 403 · see citing works

Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer

Zou, M., Toivanen, R., Mitrofanova, A., Floc’h, N., Hayati, S., Sun, Y., Magnen, C. L., Chester, D., Mostaghel, E. A., Califano, A., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1174 · Cited by 380 · see citing works

miR-34 miRNAs provide a barrier for somatic cell reprogramming

Choi, Y. J., Lin, C., Ho, J. J., He, X., Okada, N., Bu, P., Zhong, Y., Kim, S. Y., Bennett, M. J., Chen, C., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2366 · Cited by 381 · see citing works

Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST

Tsai, C., Chen, Y.-J., Yew, T., Chen, L., Wang, J., Chiu, C., & Hung, S. (2010) · Blood · doi:10.1182/blood-2010-05-287508 · Cited by 376 · see citing works

Genetic and Epigenetic Variations in iPSCs: Potential Causes and Implications for Application

Liang, G., & Zhang, Y. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.07.001 · Cited by 368 · see citing works

Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development

Karagiannis, P., Takahashi, K., Saito, M. K., Yoshida, Y., Okita, K., Watanabe, A., Inoue, H., Yamashita, J. K., Todani, M., Nakagawa, M., et al. (2018) · Physiological Reviews · doi:10.1152/physrev.00039.2017 · Cited by 367 · see citing works

Identification and Successful Negotiation of a Metabolic Checkpoint in Direct Neuronal Reprogramming

Gascón, S., Murenu, E., Masserdotti, G., Ortega, F., Russo, G. L., Petřík, D., Deshpande, A., Heinrich, C., Karow, M., Robertson, S. P., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.12.003 · Cited by 354 · see citing works

The circular RNA circBIRC6 participates in the molecular circuitry controlling human pluripotency

Yu, C.-Y., Li, T.-C., Wu, Y.-Y., Yeh, C.-H., Chiang, W., Chuang, C.-Y., & Kuo, H.-C. (2017) · Nature Communications · doi:10.1038/s41467-017-01216-w · Cited by 336 · see citing works

An Animal Model of MYC-Driven Medulloblastoma

Pei, Y., Moore, C. E., Wang, J., Tewari, A. K., Eroshkin, A. M., Cho, Y., Witt, H., Korshunov, A., Read, T., Sun, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.021 · Cited by 316 · see citing works

A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity

Ruiz, S., Panopoulos, A. D., Herrerías, A., Bissig, K., Lutz, M. K., Berggren, W. T., Verma, I., & Belmonte, J. C. I. (2010) · Current Biology · doi:10.1016/j.cub.2010.11.049 · Cited by 328 · see citing works

Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts

Wakao, S., Kitada, M., Kuroda, Y., Shigemoto, T., Matsuse, D., Akashi, H., Tanimura, Y., Tsuchiyama, K., Kikuchi, T., Goda, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100816108 · Cited by 315 · see citing works

Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation

Kumar, S. M., Liu, S.-J., Lu, H., Zhang, H., Zhang, P. J. L., Gimotty, P., Guerra, M., Guo, W., & Xu, X.-W. (2012) · Oncogene · doi:10.1038/onc.2011.656 · Cited by 330 · see citing works

Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machineryPreprint

Bezzi, M., Teo, S. X., Müller, J., Mok, W. C., Sahu, S. K., Vardy, L. A., Bonday, Z., & Guccione, E. (2013) · Genes & Development · doi:10.1101/gad.219899.113 · Cited by 302 · see citing works

Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming

Ong, A. L. C., & Ramasamy, T. S. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.02.004 · Cited by 301 · see citing works

Small RNA‐mediated regulation of iPS cell generation

Li, Z., Yang, C., Nakashima, K., & Rana, T. M. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.2 · Cited by 301 · see citing works

The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy

Kreis, N., Louwen, F., & Yuan, J. (2019) · Cancers · doi:10.3390/cancers11091220 · Cited by 309 · see citing works

Cellular senescence in development, regeneration and disease

Rhinn, M., Ritschka, B., & Keyes, W. M. (2019) · Development · doi:10.1242/dev.151837 · Cited by 296 · see citing works

Progress in understanding reprogramming to the induced pluripotent state

Plath, K., & Lowry, W. (2011) · Nature reviews genetics · doi:10.1038/nrg2955 · Cited by 306 · see citing works

EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cellsPreprint

Riggi, N., Suvà, M.-L., Vito, C. D., Provero, P., Stehle, J., Baumer, K., Cironi, L., Janiszewska, M., Petricevic, T., Suvà, D., et al. (2010) · Genes & Development · doi:10.1101/gad.1899710 · Cited by 279 · see citing works

The promises and perils of p53

Krizhanovsky, V., & Lowe, S. W. (2009) · Nature · doi:10.1038/4601085a · Cited by 274 · see citing works

Distinct Regulatory Mechanisms and Functions for p53-Activated and p53-Repressed DNA Damage Response Genes in Embryonic Stem Cells

Li, M., He, Y., Dubois, W., Wu, X., Shi, J., & Huang, J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.01.020 · Cited by 264 · see citing works

c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype

Li, Y.-Q., Li, A., Glas, M., Lal, B., Ying, M., Sang, Y., Xia, S., Trageser, D., Guerrero‐Cazares, H., Eberhart, C. G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016912108 · Cited by 266 · see citing works

Induced Pluripotent Stem Cells 10 Years Later

Yoshida, Y., & Yamanaka, S. (2017) · Circulation Research · doi:10.1161/circresaha.117.311080 · Cited by 266 · see citing works

Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential

Ohnuki, M., Tanabe, K., Sutou, K., Teramoto, I., Sawamura, Y., Narita, M., Nakamura, M., Tokunaga, Y., Nakamura, M., Watanabe, A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413299111 · Cited by 256 · see citing works

HIF1α Modulates Cell Fate Reprogramming Through Early Glycolytic Shift and Upregulation of PDK1–3 and PKM2

Prigione, A., Rohwer, N., Hoffmann, S., Mlody, B., Drews, K., Bukowiecki, R., Blümlein, K., Wanker, E. E., Ralser, M., Cramer, T., et al. (2013) · Stem Cells · doi:10.1002/stem.1552 · Cited by 252 · see citing works

Direct lineage conversions: unnatural but useful?

Vierbuchen, T., & Wernig, M. (2011) · Nature Biotechnology · doi:10.1038/nbt.1946 · Cited by 259 · see citing works

p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer

Tschaharganeh, D. F., Xue, W., Calvisi, D. F., Evert, M., Michurina, T. V., Dow, L. E., Banito, A., Katz, S. F., Kastenhuber, E. R., Weissmueller, S., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.051 · Cited by 227 · see citing works

p53 Regulates Cell Cycle and MicroRNAs to Promote Differentiation of Human Embryonic Stem Cells

Jain, A. K., Allton, K. L., Iacovino, M., Mahen, E. M., Milczarek, R. J., Zwaka, T. P., Kyba, M., & Barton, M. C. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001268 · Cited by 226 · see citing works

Deconstructing networks of p53-mediated tumor suppression in vivo

Kaiser, A. M., & Attardi, L. D. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.171 · Cited by 227 · see citing works

Basal Cell Carcinomas Arise from Hair Follicle Stem Cells in Ptch1+/− Mice

Wang, G., Wang, J., Mancianti, M., & Epstein, E. H. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.11.007 · Cited by 225 · see citing works

Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells

Liu, C., Yin, Q., Zhou, H., Wu, Y., Pu, J., Li, X., Liu, W., Huang, X. Y., Jiang, T., Wu, M., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.935 · Cited by 222 · see citing works

Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective

Liang, G., & Zhang, Y. (2012) · Cell Research · doi:10.1038/cr.2012.175 · Cited by 223 · see citing works

DNA methylation and cellular reprogramming

Carvalho, D. D. D., You, J. S., & Jones, P. A. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.08.003 · Cited by 219 · see citing works

The Use of Induced Pluripotent Stem Cells in Drug Development

Inoue, H., & Yamanaka, S. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.38 · Cited by 222 · see citing works

Cellular Differences in Protein Synthesis Regulate Tissue Homeostasis

Buszczak, M., Signer, R. A. J., & Morrison, S. J. (2014) · Cell · doi:10.1016/j.cell.2014.09.016 · Cited by 215 · see citing works

Pluripotent Stem Cells: Current Understanding and Future Directions

Romito, A., & Cobellis, G. (2015) · Stem Cells International · doi:10.1155/2016/9451492 · Cited by 224 · see citing works

Hedgehog controls neural stem cells through p53‐independent regulation of Nanog

Pò, A., Ferretti, E., Miele, E., Smaele, E. D., Paganelli, A., Canettieri, G., Coni, S., Marcotullio, L. D., Biffoni, M., Massimi, L., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.131 · Cited by 215 · see citing works

Different Facets of Aging in Human Mesenchymal Stem Cells

Wagner, W., Ho, A. D., & Zenke, M. (2010) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2009.0825 · Cited by 215 · see citing works

Dynamic single-cell imaging of direct reprogramming reveals an early specifying event

Smith, Z. D., Nachman, I., Regev, A., & Meissner, A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1632 · Cited by 205 · see citing works

Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications

Omole, A. E., & Fakoya, A. O. J. (2018) · PeerJ · doi:10.7717/peerj.4370 · Cited by 207 · see citing works

Cyclin-Dependent Kinase Inhibitor p21 Controls Adult Neural Stem Cell Expansion by Regulating Sox2 Gene Expression

Marqués‐Torrejón, M. Á., Porlan, E., Banito, A., Gómez-Ibarlucea, E., Lopez-Contreras, A. J., Fernández-Capetillo, Ó., Vidal, A., Gil, J., Torres, J., & Fariñas, I. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.12.001 · Cited by 199 · see citing works

miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma

Swarbrick, A., Woods, S. L., Shaw, A., Balakrishnan, A., Phua, Y. W., Nguyen, A., Chanthery, Y. H., Lim, L., Ashton, L. J., Judson, R. L., et al. (2010) · Nature Medicine · doi:10.1038/nm.2227 · Cited by 199 · see citing works

Targeting FAK in human cancer: from finding to first clinical trials

Golubovskaya, V. (2014) · Frontiers in bioscience · doi:10.2741/4236 · Cited by 197 · see citing works

Cycling through developmental decisions: how cell cycle dynamics control pluripotency, differentiation and reprogramming

Soufi, A., & Dalton, S. (2016) · Development · doi:10.1242/dev.142075 · Cited by 183 · see citing works

Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape

Papp, B., & Plath, K. (2011) · Cell Research · doi:10.1038/cr.2011.28 · Cited by 188 · see citing works

Targeting Programmed Cell Death Using Small‐Molecule Compounds to Improve Potential Cancer Therapy

Ke, B., Tian, M., Li, J., Liu, B., & He, G. (2016) · Medicinal Research Reviews · doi:10.1002/med.21398 · Cited by 188 · see citing works

Senescence promotes in vivo reprogramming through p16<scp>^INK</scp>^4a and <scp>IL</scp>‐6

Mosteiro, L., Pantoja, C., de Martino, A., & Serrano, M. (2018) · Aging Cell · doi:10.1111/acel.12711 · Cited by 182 · see citing works

Generation of Human Induced Pluripotent Stem Cells from Umbilical Cord Matrix and Amniotic Membrane Mesenchymal Cells*

Cai, J.-L., Li, W., Su, H.-X., Qin, D.-J., Yang, J.-Y., Zhu, F., Xu, J.-Y., He, W., Guo, X., Labuda, K., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.086389 · Cited by 184 · see citing works

A Continuous Molecular Roadmap to iPSC Reprogramming through Progression Analysis of Single-Cell Mass Cytometry

Zunder, E. R., Lujan, E., Goltsev, Y., Wernig, M., & Nolan, G. P. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.01.015 · Cited by 177 · see citing works

Molecular classification of prostate cancer using curated expression signatures

Markert, E. K., Mizuno, H., Vázquez, A., & Levine, A. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117029108 · Cited by 179 · see citing works

Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells

Mallanna, S. K., & Rizzino, A. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.05.014 · Cited by 180 · see citing works

Induced Neuronal Cells: How to Make and Define a Neuron

Yang, N., Ng, Y. H., Pang, Z. P., Südhof, T. C., & Wernig, M. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.11.015 · Cited by 180 · see citing works

Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells

Sugii, S., Kida, Y. S., Kawamura, T., Suzuki, J., Vassena, R., Yin, Y.-Q., Lutz, M. K., Berggren, W. T., Belmonte, J. C. I., & Evans, R. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910172106 · Cited by 179 · see citing works

Characterization of pluripotent stem cells

Martí, M., Mulero, L., Pardo, C., Morera, C., Carrió, M., Laricchia‐Robbio, L., Esteban, C. R., & Belmonte, J. C. I. (2013) · Nature Protocols · doi:10.1038/nprot.2012.154 · Cited by 178 · see citing works

Stem cell therapy for type 1 diabetes mellitus

Aguayo-Mazzucato, C., & Bonner-Weir, S. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.274 · Cited by 184 · see citing works

Direct Neuronal Reprogramming: Achievements, Hurdles, and New Roads to Success

Gascón, S., Masserdotti, G., Russo, G. L., & Götz, M. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.06.011 · Cited by 177 · see citing works

Present and future challenges of induced pluripotent stem cells

Ohnuki, M., & Takahashi, K. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0367 · Cited by 177 · see citing works

Aging and reprogramming: a two-way street

Mahmoudi, S., & Brunet, A. (2012) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2012.10.004 · Cited by 171 · see citing works

DNA Damage Responses in Human Induced Pluripotent Stem Cells and Embryonic Stem Cells

Momčilović, O., Knobloch, L., Fornsaglio, J. L., Varum, S., Easley, C. A., & Schatten, G. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013410 · Cited by 174 · see citing works

iPS cells: A source of cardiac regeneration

Yoshida, Y., & Yamanaka, S. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.026 · Cited by 173 · see citing works

Recent Stem Cell Advances: Induced Pluripotent Stem Cells for Disease Modeling and Stem Cell–Based Regeneration

Yoshida, Y., & Yamanaka, S. (2010) · Circulation · doi:10.1161/circulationaha.109.881433 · Cited by 171 · see citing works

PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype

Duan, S., Yuan, G., Liu, X., Ren, R., Li, J., Zhang, W., Wu, J., Xu, X., Fu, L., Li, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms10068 · Cited by 169 · see citing works

Gingival Fibroblasts as a Promising Source of Induced Pluripotent Stem Cells

Egusa, H., Okita, K., Kayashima, H., Yu, G., Fukuyasu, S., Saeki, M., Matsumoto, T., Yamanaka, S., & Yatani, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012743 · Cited by 166 · see citing works

p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewalPreprint

Zhao, Z., Zuber, J. A., Díaz-Flores, E., Lintault, L., Kogan, S. C., Shannon, K., & Lowe, S. W. (2010) · Genes & Development · doi:10.1101/gad.1940710 · Cited by 167 · see citing works

p53: Guardian of reprogramming

Ménendez, S., Camus, S., & Belmonte, J. C. I. (2010) · Cell Cycle · doi:10.4161/cc.9.19.13301 · Cited by 84 · see citing works

The Journal of Experimental Medicine CORRESPONDENCE

Sarig, R., Rivlin, N., Brosh, R., Bornstein, C., Kamer, I., Ezra, O., Molchadsky, A., Goldfinger, N., Brenner, O., Rotter, V., et al. (2013)

The p53–PUMA axis suppresses iPSC generation

Li, Y.-X., Feng, H., Gu, H., Lewis, D. W., Yuan, Y.-Z., Zhang, L., Yu, H., Zhang, P., Cheng, H.-Z., Miao, W.-M., et al. (2013) · Nature Communications · doi:10.1038/ncomms3174 · Cited by 62 · see citing works

Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells

Sarig, R., Rivlin, N., Brosh, R., Bornstein, C., Kamer, I., Ezra, O., Molchadsky, A., Goldfinger, N., Brenner, O. J., & Rotter, V. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100797 · Cited by 155 · see citing works

Context‐Dependent Enhancement of Induced Pluripotent Stem Cell Reprogramming by Silencing Puma

Lake, B. B., Fink, J., Klemetsaune, L., Fu, X., Jeffers, J. R., Zambetti, G. P., & Xu, Y. (2012) · Stem Cells · doi:10.1002/stem.1054 · Cited by 30 · see citing works